IVIG Boya: Safety, Efficacy, and Pharmacokinetics
IVIG Boya: Safety, Efficacy, and Pharmacokinetics
Not yet recruiting · NCT06150833 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IVIG Boya: Safety, Efficacy, and Pharmacokinetics | Bruton-type agammaglobulinemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Primary Immunodeficiency Diseases, common variable immunodeficiency, hereditary disease, immune system disorder, inborn error of immunity | Not yet recruiting | Phase 3 | 2026-06-03 | NCT06150833 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Azidus Brasil | 2 |
| Boya Bio Pharmaceutical Group Co Ltd | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||